{
  "trial_id": "NCT02855294",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "oral contraceptive pill",
      "label": "met",
      "evidence": "routine use for past three months"
    },
    {
      "criterion": "normal menstrual cycle",
      "label": "met",
      "evidence": "use of non-hormonal contraceptive method"
    },
    {
      "criterion": "body mass index",
      "label": "met",
      "evidence": "less than 30 Kg/m2"
    },
    {
      "criterion": "menstrual cycle duration",
      "label": "met",
      "evidence": "25-32 days for past 3 months"
    },
    {
      "criterion": "independence in standing",
      "label": "met",
      "evidence": "can stand independently"
    }
  ],
  "exclusion": [
    {
      "criterion": "respiratory or heart problems",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "skeletal deformity or assistive devices",
      "label": "not_met",
      "evidence": "no mention of skeletal deformity or assistive devices"
    },
    {
      "criterion": "visual and vestibular system affection",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "cognition problems",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "previous surgeries at back and/or lower limbs",
      "label": "not_met",
      "evidence": "no mention of previous surgeries"
    }
  ],
  "notes": "Patient has history of acne, mild hirsutism, elevated testosterone levels, gradual enlargement of hands and feet, irregular menstrual cycle, nipple discharge, snoring, headache, facial features of acromegaly, prognathism. Laboratory evaluation reveals IGF-1 of 968 ng/mL and random GH of 19.7 ng/mL. MRI shows macroadenoma with no invasion.",
  "_meta": {
    "topic_id": "20",
    "trial_id": "NCT02855294",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}